Zoetis' relfovetmab product is a long-acting anti-nerve growth factor monoclonal therapy for cats. “The benefits of Portela are significantly improved scores as assessed by cat owners using ...

Patients with knee osteoarthritis who received lorecivivint injections experienced clinically meaningful improvements in pain ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of ...

The FDA has approved a once-monthly injection of Eli Lilly’s Omvoh for maintenance therapy in adult patients with moderately ...

Almost 3 out of 4 retired players with the painful condition had suffered "significant" foot or ankle injuries during their ...

A new paper finds that retired UK male professional soccer players who reported foot or ankle injuries during their careers ...

StemWave shockwave therapy demonstrates success rates between 80-90% for chronic pain sufferers using acoustic wave technology The treatment effectively addresses joint pain, tendonitis, back pain, ...

The elbow is a relatively small joint, but it is a very common area in everyday life. Opening a door, holding things, using a ...

A new study suggests that low-dose radiation therapy could fill the treatment gap between pain medications and joint ...

For cancer treatment pain… One of the challenges posed by cancer is pain that can come from both the disease itself and the ...

“Health Canada’s approval of Lenivia [izenivetmab injection] makes it the world’s first monoclonal antibody to alleviate OA pain in dogs for 3 months,” Rob Polzer, PhD, executive vice president and ...

For the millions of people living with knee osteoarthritis, relief often comes at a cost: daily medication with diminishing returns, or surgery that demands months of recovery. But a new clinical ...